Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.9M Sell
111,802
-31,140
-22% -$12.7M 5.24% 7
2025
Q4
$44.8M Sell
142,942
-104,600
-42% -$33.2M 3.69% 10
2025
Q3
$66.8M Buy
247,542
+5,030
+2% +$1.15M 5.54% 6
2025
Q2
$53.5M Sell
242,512
-57,420
-19% -$10.3M 4.7% 9
2025
Q1
$39.3M Sell
299,932
-29,850
-9% -$4.17M 3.95% 11
2024
Q4
$45.2M Hold
329,782
3.76% 10
2024
Q3
$33.4M Sell
329,782
-1,370
-0.4% -$108K 3.01% 17
2024
Q2
$24.2M Sell
331,152
-4,230
-1% -$277K 2.41% 17
2024
Q1
$17M Sell
335,382
-6,280
-2% -$295K 1.84% 24
2023
Q4
$16M Sell
341,662
-13,450
-4% -$613K 1.84% 22
2023
Q3
$16.2M Sell
355,112
-10,994
-3% -$454K 1.92% 21
2023
Q2
$14.4M Buy
366,106
+3,640
+1% +$147K 1.7% 22
2023
Q1
$14.7M Buy
362,466
+6,720
+2% +$264K 1.76% 25
2022
Q4
$13.1M Sell
355,746
-510
-0.1% -$17.9K 1.84% 24
2022
Q3
$11.5M Sell
356,256
-75,990
-18% -$2.68M 1.71% 27
2022
Q2
$16.1M Buy
432,246
+2,100
+0.5% +$80.4K 2.37% 19
2022
Q1
$17.5M Sell
430,146
-940
-0.2% -$36.8K 2.37% 23
2021
Q4
$16.7M Buy
431,086
+3,600
+0.8% +$150K 2.21% 26
2021
Q3
$18.7M Buy
427,486
+91,760
+27% +$4.15M 2.76% 18
2021
Q2
$16M Buy
335,726
+42,103
+14% +$2.1M 2.84% 13
2021
Q1
$15.7M Buy
293,623
+64,200
+28% +$3.09M 3.47% 11
2020
Q4
$10.2M Buy
229,423
+75,540
+49% +$3.39M 3.04% 13
2020
Q3
$6.45M Buy
153,883
+73,212
+91% +$3.22M 3.01% 14
2020
Q2
$3.82M Sell
80,671
-2,350
-3% -$89.8K 2.87% 11
2020
Q1
$2.87M Sell
83,021
-48,972
-37% -$2.03M 2.37% 14
2019
Q4
$5.3M Sell
131,993
-3,050
-2% -$117K 2.63% 21
2019
Q3
$5.3M Buy
135,043
+11,490
+9% +$464K 2.92% 19
2019
Q2
$5.01M Sell
123,553
-980
-0.8% -$45.9K 2.77% 22
2019
Q1
$6.22M Sell
124,533
-410
-0.3% -$18.5K 3.52% 11
2018
Q4
$4.73M Buy
+124,943
New +$5.28M 2.97% 13

Other funds holding AGX

AltraVue Capital's AGX Position: Q1 2026 in Review

AltraVue Capital reduced its Argan (AGX) stake by 22% in Q1 2026, selling an estimated $12.7M and leaving 111,802 shares worth $60.9M. The position accounts for 5.24% of the portfolio, ranked #7.

AltraVue Capital first reported a position in AGX in Q4 2018 and has held it in 30 quarters since. The position peaked at $66.8M in Q3 2025. 495 funds tracked by Wall St. Rank hold AGX as of Q1 2026.

  • AltraVue Capital held 111,802 shares of Argan worth $60.9M as of Q1 2026.
  • AltraVue Capital sold 31,140 Argan shares in Q1 2026, an estimated $12.7M.
  • Argan made up 5.24% of AltraVue Capital's portfolio in Q1 2026, its #7 holding.
  • AltraVue Capital first reported a position in Argan in Q4 2018 and has held it in 30 quarters since.
  • AltraVue Capital's Argan position peaked at $66.8M in Q3 2025.
  • 495 funds tracked by Wall St. Rank held Argan as of Q1 2026.

Based on AltraVue Capital's 13F filing for Q1 2026, filed 13 May 2026.